Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/22/2010EP2263580A2 Treatment of skin using a benefit agent and an apparatus
12/22/2010EP2263481A1 Green tea extracts of improved bioavailability
12/22/2010EP2263480A1 Composition for promotion of bone growth and maintenance of bone health, comprising Mentha extracts
12/22/2010EP2263479A1 Synergism of GOS and polyfructose
12/22/2010EP2263478A1 Synergism of GOS and polyfructose
12/22/2010EP2263465A1 Polyvalent conjugate vaccine for cancer
12/22/2010EP2262845A1 Monomers and polymers with covalently-attached active ingredients
12/22/2010EP2262841A2 Process for preparation of amine polymer salt
12/22/2010EP2262821A2 Process for the extraction of mangiferin and isomangiferin
12/22/2010EP2262818A1 Crystalline phospholipid, method for its production and use in treating damaged tissue
12/22/2010EP2262815A1 Inhibitors of protein tyrosine kinase activity
12/22/2010EP2262811A1 1,2,4-triazolo[4,3-c]pyrimidin-3-one and pyrazolo [4,3-e]-1,2,4-triazolo [4,3-c]pyrimidin-3-one compounds for use as adenosine a2a receptor antagonists
12/22/2010EP2262810A2 Novel 1,4-diaza-bicyclo[3.2.1]octane derivatives useful as nicotinic acetylcholine receptor modulators
12/22/2010EP2262809A1 Benzophenone-piperazine linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof
12/22/2010EP2262807A1 Novel tyrosine kinase inhibitors
12/22/2010EP2262806A1 Pyrrolotriazine kinase inhibitors
12/22/2010EP2262805A1 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof
12/22/2010EP2262804A1 Polysubstituted derivatives of 6-heteroaryl-imidazo[l,2- a] pyridines, and preparation and therapeutic use thereof
12/22/2010EP2262803A1 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof
12/22/2010EP2262802A1 Pim kinase inhibitors and methods of their use
12/22/2010EP2262801A1 Heterocyclic urea derivatives and methods of use thereof-211
12/22/2010EP2262800A1 Novel pyrimidine-pyridine derivatives
12/22/2010EP2262799A1 Pyridine compounds
12/22/2010EP2262797A1 Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof
12/22/2010EP2262796A1 Aurora kinase inhibitors
12/22/2010EP2262795A1 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof
12/22/2010EP2262793A2 Nilotinib hci crystalline forms
12/22/2010EP2262792A1 Substituted sulfonamide derivatives
12/22/2010EP2262791A2 Substituted sulfonamide derivatives
12/22/2010EP2262790A1 Crystal of benzimidazole compound
12/22/2010EP2262789A1 2-aminoquinolines
12/22/2010EP2262787A1 Use of xanthone derivatives as a medicament for cancer
12/22/2010EP2262786A2 Colchicine solid-state forms; methods of making; and methods of use thereof
12/22/2010EP2262785A1 Benzofurane, benzothiophene, benzothiazol derivatives as fxr modulators
12/22/2010EP2262784A1 Inhibitors of the chemokine receptor cxcr3
12/22/2010EP2262783A2 Covalently binding imaging probes
12/22/2010EP2262782A1 Novel aminomethyl benzene derivatives
12/22/2010EP2262781A1 Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors
12/22/2010EP2262778A2 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxcr1 and p40
12/22/2010EP2262777A2 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cri
12/22/2010EP2262775A1 (e)-n-(2-amino-phenyl)-3-{1-[4-(1-methyl-1h-pyrazol-4-yl)-benzenesulfonyl]-1h-pyrrol-3-yl}-acrylamide salts
12/22/2010EP2262774A2 2-aminoquinolines
12/22/2010EP2262773A1 2-aminoquinoline derivatives
12/22/2010EP2262772A1 Quinoline derivatives as axl kinase inhibitors
12/22/2010EP2262770A1 2-trifluoromethylnicotinamide derivatives as hdl-cholesterol raising agents
12/22/2010EP2262769A1 Polysubstituted 2-aryl-6-phenyl-imidazo[1,2-a]pyridine derivatives, and preparation and therapeutic use thereof
12/22/2010EP2262768A2 Preparation of lenalidomide
12/22/2010EP2262767A1 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors
12/22/2010EP2262765A1 Stabilized 1,25-dihydroxyvitamin d2 and method of making same
12/22/2010EP2262764A2 Novel n-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents
12/22/2010EP2262763A2 Compounds and methods of treating obesity
12/22/2010EP2262758A2 O-desmethylvenlafaxine salts
12/22/2010EP2262754A2 Minocycline compounds and methods of use thereof
12/22/2010EP2262536A2 Stabilizing lipid compositions for oral pharmaceutical agents
12/22/2010EP2262535A1 Use of a composition containing healing earth as an antacid
12/22/2010EP2262524A2 Compositions and methods for treating pathologic angiogenesis and vascular permeability
12/22/2010EP2262523A1 Improved anticancer treatments
12/22/2010EP2262522A1 Improved antitumoral treatments
12/22/2010EP2262521A1 Ophthalmic compositions comprising a dipeptide
12/22/2010EP2262519A2 Treatment of hearing and balance impairments with redox-active therapeutics
12/22/2010EP2262508A2 SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
12/22/2010EP2262507A1 Methods of increasing epidermal skin thickness by topical administration of a 19-nor containing vitamin d compound
12/22/2010EP2262506A1 Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
12/22/2010EP2262505A2 Substituted heterocycle fused gamma-carbolines solid
12/22/2010EP2262504A1 Combination therapy 238
12/22/2010EP2262503A1 Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques
12/22/2010EP2262502A1 Compositions and methods for alleviating depression or improving cognition
12/22/2010EP2262501A2 Treatment of sepsis with 5-ethyl-1-phenyl-2(1h)-pyridone and novel methods for synthesis
12/22/2010EP2262500A1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
12/22/2010EP2262499A1 Method of treating cancer using a neuropeptide y 5r (np y5r) antagonist
12/22/2010EP2262498A2 Pyrimidines and pyridines useful as inhibitors of protein kinases
12/22/2010EP2262497A2 S1p3 receptor inhibitors for treating inflammation
12/22/2010EP2262496A1 Compounds and compositions as modulators of gpr119 activity
12/22/2010EP2262495A2 Pharmaceutical composition comprising racetam and carnitine and process for its preparation
12/22/2010EP2262494A2 Inhibition of post-radiation tumor growth by an inhibitor of vasculogenesis
12/22/2010EP2262493A1 Methods of treatment employing prolonged continuous infusion of belinostat
12/22/2010EP2262492A2 Methods of treating hyperacidic disorders
12/22/2010EP2262491A1 Therapy for disorders of the proximal digestive tract
12/22/2010EP2262488A1 Colchicine solid complex; methods of making; and methods of use thereof
12/22/2010EP2262486A1 Quetiapine composition
12/22/2010EP2262485A1 Modified release composition comprising doxofylline
12/22/2010EP2262484A1 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
12/22/2010EP2262483A2 Modified release pharmaceutical compositions comprising mycophenolate and processes thereof
12/22/2010EP2262482A1 Controlled release drug delivery systems and pharmaceutical compositions formed therewith
12/22/2010EP2262481A2 Bupivacaine formulation in a polyorthoester carrier
12/22/2010EP2262479A2 Amorphous arformoterol l-(+)-tartrate
12/22/2010EP2262478A2 Activated nitric oxide donors and methods of making and using thereof
12/22/2010EP2262477A1 Process for preparing concentrated aqueous micellar solutions
12/22/2010EP2262475A1 Chewable tablet and method of formulating
12/22/2010EP2262371A1 Lpa receptor agonists and antagonists
12/22/2010EP2262370A1 Di-fluoro containing compounds as cysteine protease inhibitors
12/22/2010EP2262369A1 Lipid-oil-water nanoemulsion delivery system for microtubule-interacting agents
12/22/2010EP2262367A2 Oral pharmaceutical compositions of buprenorphine and method of use
12/22/2010EP2262366A1 Compounds and methods for treating estrogen receptor-related diseases
12/22/2010EP2262365A2 Use of '-thio-2'-deoxynucleosides as anri orthopoxvirus agents
12/22/2010EP2262364A2 Oxadiazoanthracene compounds for the treatment of diabetes
12/22/2010EP2178873B1 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors
12/22/2010EP2094684B1 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin 2-ones as cb1 receptor modulators
12/22/2010EP2089020B1 Macrocyclic peptides as hepatitis c virus inhibitors
12/22/2010EP2086980B1 Macrocyclic peptides as hepatitis c virus inhibitors
1 ... 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 ... 7860